Virginie Bros-Facer to step down as CEO of EURORDIS

Virginie Bros-Facer to step down as CEO of EURORDIS September 2025 9 September 2025, Paris – EURORDIS-Rare Diseases Europe announces that Virginie Bros-Facer has taken the decision to step down from her role as Chief Executive Officer. She will leave the organisation on 30 September 2025. https://www.eurordis.org/virginie-bros-facer-step-down-ceo/ EURORDIS CEO update This month, EURORDIS announced that Virginie Bros-Facer, Chief Executive Officer, will step down from her role and leave the organisation on 30 September. Virginie Hivert, our current Head of Therapies and Access, will serve as Acting CEO. Our Board has launched the search for a new CEO to guide our next chapter. “While we are saddened to lose Virginie,” said EURORDIS President Avril Daly, “we are deeply thankful for the leadership she has shown”.